# Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis

> **NCT00216879** · PHASE3 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 800 (—)

## Conditions studied

- Psoriasis of Scalp

## Interventions

- **DRUG:** Calcipotriol plus betamethasone dipropionate gel (LEO 80185)

## Key facts

- **NCT ID:** NCT00216879
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 800 (—)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00216879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00216879, "Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel for up to a Year in Scalp Psoriasis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00216879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*